Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J0MD
|
|||
| Former ID |
DNC007844
|
|||
| Drug Name |
(Z)-4-(4-hexylphenylamino)-4-oxobut-2-enoic acid
|
|||
| Synonyms |
Substituted Acrylamide, 7b; CHEMBL235904; BDBM18847; (2Z)-3-[(4-hexylphenyl)carbamoyl]prop-2-enoic acid; (2z)-4-[(4-hexylphenyl)amino]-4-oxobut-2-enoic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H21NO3
|
|||
| Canonical SMILES |
CCCCCCC1=CC=C(C=C1)NC(=O)C=CC(=O)O
|
|||
| InChI |
1S/C16H21NO3/c1-2-3-4-5-6-13-7-9-14(10-8-13)17-15(18)11-12-16(19)20/h7-12H,2-6H2,1H3,(H,17,18)(H,19,20)/b12-11-
|
|||
| InChIKey |
OOWYMHDWBQTCOX-QXMHVHEDSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Thyroid hormone receptor alpha (THRA) | Target Info | Inhibitor | [1] |
| Thyroid hormone receptor beta (THRB) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Thyroid hormone signaling pathway | ||||
| Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | |||
| Reactome | Nuclear Receptor transcription pathway | |||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Hematopoietic Stem Cell Differentiation | ||||
| Nuclear Receptors | ||||
| Endochondral Ossification | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships. J Med Chem. 2007 Nov 1;50(22):5269-80. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.